论文部分内容阅读
The European Clinical Laboratory and Molecular(ECLM)criteria define 10 distinct Willebrand diseases(VWD):recessive type 3,severe 1,2C and 2N;dominant VWD type 1 secretion/clearance defect,2A,2B,2E,2M and 2D;and mild type 1 VWD(usually carriers of recessiv